Based on the success of our HX @ ASCO 2012 conference, Healthios Capital Markets, a Chicago-based boutique investment bank focused exclusively on the emerging healthcare community, is proud to annouce our exclusive partnering event preceding ASCO this year, Friday May 31 at the Union League Club, in Chicago.
Our 2012 partnering event attracted strategics such as Abbott Laboratories, Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Celgene, EMD Serono, Forest Laboratories, Genentech, GlaxoSmithKline, Ipsen, MedImmune, Merck, Millennium Pharma, Novartis, Pfizer, Roche, Sanofi, Sunovion and Teva. So far, the following have confirmed for 2013: Amgen, Astellas, Baxter, Celgene, Daiichi Sankyo, Eli Lilly, Forest Labs, Gilead, GSK, Merck, Novartis, Pfizer, Roche Oncology Partnership and Sunovian.
The following emerging growth biotechnology companies in the strategically important areas of epigenetics, cancer stem cells (CSCs), immunotherapy, tumor microenvironment, tumor metabolism, anti-angiogenesis, tumor targeting, and next generation cytotoxics have confirmed: CDG Therapeutics, Cleave Biosciences, Dicerna Pharmaceuticals, Epic Sciences, Five Prime Therapeutics, G1 Therapeutics, GlobeImmune, Groove Biopharma, Igenica, Immune Design, Mirna Therapeutics, Oncofactor Corp., PhaseRx, RA Pharmaceuticals, Sun Biopharma, Syndax Pharmaceuticals, Theraclone Sciences and Tragara Pharmaceuticals.
Kicking off H/X @ ASCO 2013 will be one-on-one meetings followed by a luncheon/keynote address: "Is It Too Risky to Invest in Biotherapeutics?"
Healthios is an investment bank focused exclusively on the emerging growth healthcare community: strategic buyers, institutional investors and their portfolio companies – with a practice dedicated to Oncology Therapeutics. The Healthios Exchange (“H/X”) is a unique research platform which enables invited users to access the resources, research and relationships which are fundamental to superior value creation. Our partnering events are extensions of the H/X, as we believe partnering to be at the core of innovative new medicines in Oncology.
For more information on Healthios Crowdfunding Platform, HealthiosXchange, please click on the link, http://www.healthiosexchange.com/ and click "Join Now."